Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Oncology Institute, Inc. ( (TOI) ).
Maeve O’Meara plans to resign from The Oncology Institute’s Board of Directors by January 1, 2025, not due to any internal disputes. Gabriel Ling will step in as an independent director, ensuring a majority of independent directors in compliance with Nasdaq rules, maintaining stability and governance for investors.
For a thorough assessment of TOI stock, go to TipRanks’ Stock Analysis page.